Global Paget Disease Treatment Market Size Projected to Reach $2.52 Billion During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Paget Disease Treatment Market Expected To Expand Between 2025 And 2029?

The paget disease treatment market size has experienced consistent expansion in recent years. It is projected to increase from $2.12 billion in 2024 to $2.19 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.2%. The expansion observed in previous periods can be linked to factors like the rising prevalence of paget disease, improved awareness and diagnosis rates, an expanding geriatric population, advancements in healthcare infrastructure, and the growing adoption of bisphosphonates.

The paget disease treatment market is anticipated to observe consistent growth over the next few years, with its valuation expected to reach $2.52 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 3.6%. This projected growth stems from factors such as increasing demand for targeted therapies, rising healthcare expenditure, a growing aging population, an increase in clinical trials for novel therapies, and an enhanced focus on personalized medicine. Significant trends for the forecast period include advancements in treatment options, a shift towards biologic treatments, the development of combination therapies, the integration of digital health solutions, and progress in diagnostic technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22088&type=smp

What Are The Top Growth Drivers Impacting The Paget Disease Treatment Market Outlook?

The paget disease treatment market is anticipated to expand due to an increase in arthritis and bone injury cases. Arthritis, characterized by joint inflammation, can be aggravated by bone injuries. The rise in these conditions is often linked to insufficient physical activity, which diminishes muscle and joint strength, impairing their capacity to support movement and absorb impacts. This elevates the risk of joint degeneration, stiffness, and fractures over time. Paget disease treatment aids in managing arthritis and bone injuries by alleviating bone pain, improving joint functionality, and preventing issues like fractures and deformities resulting from abnormal bone remodeling. For example, in February 2024, The Centers for Disease Control and Prevention (CDC), a US-based national public health institute, reported that in 2022, the age-adjusted prevalence of diagnosed arthritis among adults aged 18 and older was 18.9%. Women showed a higher prevalence at 21.5% compared to men at 16.1%. The prevalence of arthritis also increased with age, from 3.6% in individuals aged 18–34 to 53.9% in those aged 75 and above. Thus, the escalating incidence of arthritis and bone injuries is a key driver for the growth of the paget disease treatment market.

What Are The Major Segments Identified In The Paget Disease Treatment Market?

The paget disease treatmentmarket covered in this report is segmented –

1) By Treatment Type: Actonel; Reclast; Zoledronic Acid; Fosamax; Miacalcin; Aredia; Calcitonin; Zometa; Other Treatments

2) By Route Of Administration: Oral; Intravenous; Topical

3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Pharmacie; Drug stores

4) By End User: Hospitals; Clinics; Other End-Users

Subsegments:

1) By Actonel: Risedronate Sodium Tablets; Delayed-Release Risedronate.

2) By Reclast: Intravenous Reclast; Annual Reclast Infusion.

3) By Zoledronic Acid: Zoledronic Acid 5 mg Injection; Zoledronic Acid 4 mg Injection.

4) By Fosamax: Alendronate Sodium Tablets; Alendronate Oral Solution

5) By Miacalcin: Miacalcin Nasal Spray; Miacalcin Injection

6) By Aredia: Pamidronate Disodium 30 mg Injection; Pamidronate Disodium 90 mg Injection

7) By Calcitonin: Synthetic Salmon Calcitonin; Human Calcitonin

8) By Zometa: Zometa 4 mg/5 mL Concentrate; Zometa 4 mg Infusion

9) By Other Treatments: Pain Management Medications; Physical Therapy; Surgical Interventions

What Are The Latest Industry Trends Transforming The Paget Disease Treatment Market?

Leading companies in the paget disease treatment market are concentrating on developing innovative products, such as calcium regulators, to improve treatment efficacy, enhance patient outcomes, and increase their market share. A calcium regulator is a substance or medication that aids in managing calcium levels within the blood and bones, ensuring balance to support various physiological processes. For example, Fresenius Kabi AG, a Germany-based healthcare company, launched Calcitonin Salmon Injection, USP Synthetic, a calcium regulator designed for treating symptomatic Paget’s disease of the bone, hypercalcemia, and postmenopausal osteoporosis, in February 2025. This launch aims to offer a more economical treatment solution, strengthen their supply chain, and expand their portfolio of generic injectables. Fresenius Kabi has made considerable investments in its facilities to secure a steady provision of essential medicines, with the objective of improving patient care and establishing itself as a key healthcare provider.

Which Major Firms Are Strengthening Their Position In The Paget Disease Treatment Industry?

Major companies operating in the paget disease treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Apotex Inc., Sumitomo Pharma Co. Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Endo International plc, Zaklady Farmaceutyczne Polpharma S.A., Abiogen Pharma S.p.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/paget-disease-treatment-global-market-report

Which Region Currently Holds The Largest Share Of The Paget Disease Treatment Market?

North America was the largest region in the paget disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the paget disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Paget Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=22088&type=smp

Browse Through More Reports Similar to the Global Paget Disease Treatment Market 2025, By The Business Research Company

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Chronic Disease Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795